Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2002-03-13
2009-02-10
Yu, Misook (Department: 1642)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
active
07488479
ABSTRACT:
A novel gene (designated 125P5C8) and its encoded protein, and variants thereof, are described wherein 125P5C8 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 125P5C8 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 125P5C8 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 125P5C8 can be used in active or passive immunization.
REFERENCES:
patent: 2211504 (1989-07-01), None
patent: WO0175067 (2001-10-01), None
patent: WO0194629 (2001-12-01), None
patent: WO0210449 (2002-02-01), None
patent: WO0226982 (2002-04-01), None
patent: WO02055700 (2002-07-01), None
patent: WO02068677 (2002-09-01), None
patent: WO02070539 (2002-09-01), None
patent: WO02072785 (2002-09-01), None
patent: WO03050236 (2003-06-01), None
Tockman et al (Cancer Res., 1992, 52:2711s-2718s).
Greenbaum et al. (Genome Biology, 2003, vol. 4, Issue 9, pp. 117.1-117.8).
Alberts et al (Molecular Biology of the Cell, 3rd edition, 1994, p. 465).
Lewin (Genes VI, Oxford University Press, Inc., NY, Chapter 29, 1997).
Fu et al (EMBO Journal, 1996, vol. 15, pp. 4392-4401).
Mallampalli et al (Biochem. J. vol. 318, 1996, pp. 333-341).
Prewett et al (Clinical Cancer Research, 1998, 4:2957-2966).
Mc Neil (JNCI, 90(12):882-883).
Lu et al (Nature Biotechnology, Jan. 2007, 25(1):117-124).
Kirkin et al (1998, APMIS, 106 : 665-679).
Chaux et al, (Int J Cancer, 1998, 77: 538-542).
Abdel-Malek, J. Cell Physiol. (1988) 136:247.
Abe and Saito, J. Neurochem. (2001) 76:217-223.
Batra et al., Prostate. (1991) 19:299.
Cell Growth Differ. (2000) 11:279.
Craft et al., Cancer Res. (1999) 59:5030-5036.
Davies et al., Science (2000) 290:2295.
Filetti et al., Eur. J. Endocrinol. (1999) 141:443.
Fu et al., Int. J. Cancer (1992) 52(6):987-990.
Gergely et al., Clin. Diagn. Lab. Mannual (1997) 4:70.
Hollo et al., Biochimica et Biophysica Acta (1994) 1191:384.
Howell, Molecular Urology (1999) 3(3):295-302.
Hubert et al., Proc. Natl. Acad. Sci. USA (1999) 96(25):14523-14528.
Ivanov and Ronai, Oncogene (2000) 19:3003.
Jain, Cancer and Metastasis Reviews (1990) 9:253-266.
Janulis et al., J. Biol. Chem. (1999) 274:801.
Krueger et al., Cancer Res. (1999) 59:6010.
Kaighn et al., Invest. Urol. (1979) 17(1):16-23.
Klein et al., Nature Med. (1997) 3:402-408.
Kubota, J. Cell Biochem. (1994) 56(1):4-8.
Leith et al., Blood (1995) 86:2329.
Linsley et al., J. Exp. Med. (1991) 174:561-566.
Morton and Myszka, Methods in Enzymology (1998) 295:268.
Musil et al., J. Biol. Chem. (2000) 275:25207.
Pemberton et al., J. of Histochemistry and Cytochemistry (1997) 45:1697-1706.
Saffran et al., PNAS (2001) 98(5):2658-2663.
Skryma et al., J. Physiol. (2000) 527:71.
Spitzweg et al., Cancer Res. (2000) 60:6526.
Storrie et al., Methods Enzymol. (1990) 182:203-225.
Tazebay et al., Nat. Med. (2000) 6:871.
Welford, Opt. Quant. Elect. (1991) 23:1.
Klein et al., Nat. Med. (1997) 3:402.
Pinto et al., Clin. Cancer Res. (1996) 2(9):1445-1451.
Reiter et al., Proc. Natl. Acad. Sci. USA (1998) 95:1735.
Su et al., Proc. Natl. Acad. Sci. USA (1996) 93:7252.
Chen, Current Opinion in Immunology (1999) 11(2):219-222.
Database UniProt, accession No. Q9H720 (Mar. 2001).
Supplementary Partial European Search Report for EP 02726630.3, mailed on Jan. 10, 2007, 4 pages.
GenCore databases, Amino acid and nucleic acid databases, SEQ ID No.: 1 and 2, Accession Nos. Q9H720 and AK025164, ten sheets. Mar. 2000 and Sep. 2000.
Lazar et al., Molecular and Cellular Biology (1988) 8(3):1247-1252.
Restriction Requirement for U.S. Appl. No. 09/809,638, mailed on Jun. 6, 2002.
Amendment and Response to Restriction Requirement for U.S. Appl. No. 09/809,638, filed on Aug. 6, 2002.
Restriction Requirement for U.S. Appl. No. 09/809,638, mailed on Nov. 18, 2002.
Response to Restriction Requirement and Amendment for U.S. Appl. No. 09/809,638, filed on Dec. 18, 2002.
Non-Final Office Action for U.S. Appl. No. 09/809,638, mailed on Mar. 7, 2003.
Amendment and Response for U.S. Appl. No. 09/809,638, filed on Jul. 11, 2003.
Non-Final Office Action for U.S. Appl. No. 09/809,638, mailed on Oct. 7, 2003.
Amendment in Response for U.S. Appl. No. 09/809,638, filed on Feb. 9, 2004.
Final Office Action for U.S. Appl. No. 09/809,638, mailed on May 19, 2004.
Response to Final Office Action for U.S. Appl. No. 09/809,638, filed on Jun. 10, 2004.
Non-Final Office Action for U.S. Appl. No. 09/809,638, mailed on Oct. 4, 2004.
Amendment in Response to Non-Final Office Action for U.S. Appl. No. 09/809,638, filed on Dec. 7, 2004.
Final Office Action for U.S. Appl. No. 09/809,638, mailed on Feb. 16, 2005.
Amendment After Final Action for U.S. Appl. No. 09/809,638, filed on Apr. 18, 2005.
Supplemental Response to Amendment After Final Action for U.S. Appl. No. 09/809,638, filed on May 9, 2005.
Advisory Action for U.S. Appl. No. 09/809,638, mailed on Aug. 17, 2005.
Response to Advisory Action and Request for Continued Examination for U.S. Appl. No. 09/809,638, filed on Nov. 2, 2005.
Supplemental Response for U.S. Appl. No. 09/809,638, filed on Nov. 3, 2005.
Non-Final Office Action for U.S. Appl. No. 09/809,638, mailed on Jan. 3, 2006.
Response to Non-Final Office Action for U.S. Appl. No. 09/809,638, filed on Mar. 15, 2006.
Final Office Action for U.S. Appl. No. 09/809,638, mailed on Aug. 4, 2006.
Amendment After Final Action for U.S. Appl. No. 09/809,638, filed Sep. 29, 2006.
Notice of Allowance fro U.S. Appl. No. 09/809,638, mailed on Feb. 22, 2007.
Request for Continued Examination for U.S. Appl. No. 09/809,638, filed on May 22, 2007.
Notice of Allowance for U.S. Appl. No. 09/809,638, mailed on Jun. 26, 2007.
European Office Action for EP Patent Application No. 02726630.3, mailed on Aug. 27, 2007.
Afar Daniel E. H.
Challita-Eid Pia M.
Faris Mary
Ge Wangmao
Hubert Rene S.
Aeder Sean
Agensys, Inc.
Morrison & Foerster / LLP
Yu Misook
LandOfFree
Nucleic acid and corresponding protein entitled 125P5C8... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid and corresponding protein entitled 125P5C8..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid and corresponding protein entitled 125P5C8... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4080358